Breaking AI & Tech News Analyzed

The play 'In the Print' is a tense thriller that dramatizes the 1986-87 stand-off between Rupert Murdoch and Brenda Dean, general secretary of the print union Sogat. The play, written by Robert Khan and Tom Salinsky, explores the Wapping dispute, a pivotal moment in British industrial relations.The play's central plot revolves around Murdoch's attempt to reform newspaper production and the union's resistance to these changes. Murdoch's use of a fake newspaper, The London Post, to justify the relocation of his titles to a deunionized workforce in Wapping is a key element of the play.The production, briskly staged by Josh Roche, features strong performances from the cast, including Alan Cox as Murdoch, Claudia Jolly as Dean, and Russell Bentley as Kelvin MacKenzie, the then editor of the Sun. The play leaves audiences to decide whether Dean was outplayed by Murdoch or if militant trade unionism was already on the decline.The play is part of a series of stage dramatizations of Murdoch's life and career, including James Graham's Ink and Murdoch: The Final Interview. 'In the Print' offers a unique perspective on Murdoch's revolutionary approach to industrial relations and his impact on British conventions.

The UK's National Health Service (NHS) is facing potential medicine shortages due to supply chain disruptions, with the head of NHS England, Jim Mackey, warning that some medicines could run out in weeks or even days. Mackey cited the country's reliance on imports, with 75% of medicines coming from abroad, as a major concern.Mackey revealed that a team is in place to focus on identifying potential risks in the supply chain, and that the NHS is working to mitigate the impact of any disruptions. He stated that the NHS generally has enough medicine to last a few weeks, but that some products may only have days' worth of supply.The concerns about medicine shortages come amid the ongoing conflict in the Middle East, which has raised worries about cost implications and supply disruption. Experts have noted that pharmacies are seeing disturbing spikes in prices, which can be an early indicator of challenges.The UK government has stated that there are currently no reported medicine shortages as a result of the conflict, but that they are monitoring the situation closely and have established processes in place to manage disruption across the health and social care sector.

US Secretary of State Marco Rubio has assured that the Strait of Hormuz will reopen after the ongoing conflict with Iran. In an exclusive interview with Al Jazeera, Rubio emphasized that the strait will be reopened either with Iran's consent or through an international coalition including the US.The conflict began on February 28 with US-Israeli strikes on Iran. Despite US President Donald Trump stating that the US is pursuing diplomacy, Rubio mentioned ongoing direct talks between the US and Iran, primarily through intermediaries. Iran has denied these talks are happening.Rubio called on Iran to take concrete steps to end its nuclear programme and cease manufacturing drones and missiles. He accused Iran of seeking nuclear weapons to threaten and blackmail the world, which Tehran denies.The situation remains volatile, with speculation about a possible US troop deployment in Iran. Rubio warned of severe consequences if Iran keeps the strait closed after the conflict ends. The White House has considered various military options, including a special forces operation to seize enriched uranium stored in Iran.

In an exclusive interview with Al Jazeera, US Secretary of State Marco Rubio revealed that President Donald Trump favors diplomacy as a means to end the conflict with Iran. Rubio emphasized that direct talks between the US and Tehran are currently underway through intermediaries.Earlier, Trump threatened to target Iran's civilian energy infrastructure, including power plants, oil wells, and Kharg Island, if Tehran did not reopen the Strait of Hormuz. Despite these military threats, Rubio's comments suggest a preference for diplomatic engagement.

The recent open letter from 60 clergy members, addressed to the author, underscores a shared concern for planetary stewardship and acknowledges that human‑generated carbon emissions are warming the climate. However, the signatories and the author diverge sharply on the appropriate policy response. Marshall contends that an outright ban on fossil fuels is both impractical and ideologically driven, creating a collective‑action dilemma for the UK. He notes that while the nation pursues a rapid net‑zero transition, major emitters such as India and China operate on markedly different timelines, and the United States has withdrawn from the Intergovernmental Panel on Climate Change (IPCC). This leaves Britain navigating a path of unilateral economic disarmament. Industrial electricity rates in the UK have surged to two‑and‑a‑half to three times those in China and four times those in the United States. Such cost differentials are eroding the global competitiveness of sectors ranging from steel and oil refining to chemicals, automotive manufacturing, and emerging AI industries. The result, according to Marshall, is a wave of factory closures, investment pull‑backs, and significant job losses across the nation's industrial heartlands. Beyond macro‑economic concerns, the policy’s social toll is stark. Older and low‑income households are bearing the brunt of soaring energy bills, with an estimated 2,500 excess deaths last year attributed to an inability to adequately heat homes. This humanitarian impact, Marshall argues, contradicts the very notion of “human flourishing” that climate advocates champion. While acknowledging that every policy entails trade‑offs, Marshall warns that the clergy’s proposal would impose severe personal costs on working‑class Britons without delivering the promised climate benefits. He concludes that the current net‑zero trajectory is unlikely to curb global warming and instead jeopardizes the UK's economic vitality and social wellbeing. Paul MarshallChair, Marshall Wace; personal investor in GB News

The recent arrival of US ground invasion forces in the Middle East has raised concerns about a potential military confrontation with Iran. With 5,000 marines and 2,000 paratroopers deployed, the US may attempt to forcibly open the Strait of Hormuz, a vital waterway through which a fifth of the world's oil trade passes.Iran's control over the strait gives it significant leverage, and any US action could lead to severe escalation. The US president, Donald Trump, has stated he is prepared to give diplomacy a chance, but he also expressed a desire to 'take the oil in Iran'. The situation is precarious, with experts warning of a high risk of casualties and escalation.There are two possible military options for the US to open the strait: seizing territory or deploying a massive naval presence. However, both options carry significant risks. Iran has threatened to carpet bomb its own territory to kill any American soldiers on its soil, and the US would need a substantial force to hold any territory.The deployment may be a show of force to strengthen the American negotiating position, but it could also lead to a more significant conflict. The challenge could be multiplied if Iran-allied Houthi forces in Yemen enter the conflict, potentially attacking vessels passing through the southern end of the Red Sea.

Donald Trump has issued a stark warning to Iran, threatening to "obliterate" its power stations and fresh water plants if a peace deal is not reached soon. This comes as the US and Israel's joint war against Iran enters its second month, with Tehran remaining defiant in the face of US peace proposals.The conflict has already had significant repercussions, including a record monthly rise in oil prices and concerns over a potential US ground operation to seize Kharg Island. Trump's threat to destroy civilian infrastructure, such as power and water facilities, has been condemned by human rights groups as a potential war crime.The White House has also suggested that Arab countries may be asked to help foot the bill for the war, adding a new dimension to the conflict. "It's an idea that I know that he has," said White House press secretary Karoline Leavitt.International pressure is mounting, with Spain closing its airspace to US planes involved in the conflict and the UK's prime minister reiterating that "this is not our war and we are not going to get dragged into it". Egypt's president, Abdel Fattah al-Sisi, has called on Trump to end the war, warning that "no one will be able to stop the war in our region".The conflict threatens to plunge the global economy into recession and trigger shortages of food and pharmaceuticals. The International Monetary Fund has warned that "all roads lead to higher prices and slower growth worldwide" if the conflict continues.

Eli Lilly, the US pharmaceutical group behind the Mounjaro weight-loss drug, is seeking to resume its investments in the UK after pausing them last year. The company is in talks with UK ministers to regularly increase NHS drug prices and end a rebate scheme. Patrik Jonsson, president of Eli Lilly's international business, expressed optimism about reaching an agreement this summer.The talks will also explore 'innovative' pricing plans, such as linking payments for anti-obesity drugs to whether the treatment helps patients return to work. This comes as the US pharmaceutical industry increases pressure on the UK, with Keir Starmer agreeing to the first increase in NHS cost-effectiveness thresholds in 27 years. The threshold was raised from £20,000 to £30,000 a year for every year of life gained to £25,000 to £35,000.Eli Lilly was one of several pharmaceutical companies that ditched or paused almost £25bn in planned investments in the UK last year. The company paused its plans to invest in a laboratory site in central London. Jonsson stated that the resumption of Eli Lilly's investment would depend on the outcome of its talks with the government.He emphasized that prices for medicines in the UK had been 'far too low for far too long' and that the threshold couldn't remain static for another three decades. The UK agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal, which could eventually reach £9bn a year.Large pharmaceutical companies have protested about a 'rebate' scheme, under which they are required to pay back a chunk of revenue from sales of branded medicines. This scheme is expected to fall in 2026, although Jonsson believes payments 'should actually get down to zero' over time.

Alim Beisembayev, the Kazakh-born winner of the 2021 Leeds International Piano Competition, presented a compelling piano recital that traversed the Romantic era, from Schubert to Liszt. His performance was marked by intimacy and conviction, bringing to life the passionate surge of Romanticism over three decades.Beisembayev's approach to Schubert's Moments Musicaux, D780 was characterized by calmness and understatement, effectively highlighting the vast contrast with the Liszt that followed. He skillfully utilized the fine acoustic of the Dora Stoutzker hall to create an intimate atmosphere, where Schubert's characteristic slipping between major and minor modes was quietly evocative.In his rendition of Chopin's Fantaisie, Op49, Beisembayev demonstrated a strong affinity with the composer, shaping long arching melodies and capturing their particular melancholy. His keyboard manner was both composed and contained, yet fired volleys of notes with fierce conviction. This approach seemed to embody Schumann's observation that Chopin's works were 'cannon buried in flowers.'The program's coherence was further underscored by the key of F minor, which also pointed to the interval of a diminished 5th, perceived as the Diabolus in Musica in Liszt's Sonata in B minor. Beisembayev's precise management of Liszt's transitions from apocalyptic turmoil to serene melody spinning, punctuated by moments of silence, showcased his technical assurance and deeper interpretative insights.The recital concluded with a Debussy encore that seamlessly transitioned into the 20th century, offering liquid balm beautifully delivered.